# Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer

> **NCT00096278** · PHASE3 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 2710 (actual)

## Conditions studied

- Colon Adenocarcinoma
- Stage IIA Colon Cancer AJCC v7
- Stage IIB Colon Cancer AJCC v7
- Stage IIC Colon Cancer AJCC v7
- Stage IIIA Colon Cancer AJCC v7
- Stage IIIB Colon Cancer AJCC v7
- Stage IIIC Colon Cancer AJCC v7

## Interventions

- **BIOLOGICAL:** Bevacizumab
- **DRUG:** Fluorouracil
- **DRUG:** Leucovorin Calcium
- **DRUG:** Oxaliplatin

## Key facts

- **NCT ID:** NCT00096278
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09-15
- **Primary completion:** 2009-03-12
- **Final completion:** 2012-12-31
- **Target enrollment:** 2710 (ACTUAL)
- **Last updated:** 2019-07-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00096278

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00096278, "Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00096278. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*